ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
PAVmed Inc

PAVmed Inc (PAVM)

0.645
0.063
(10.82%)
Closed December 23 3:00PM
0.579
-0.066
(-10.23%)
After Hours: 6:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.579
Bid
0.57
Ask
0.59
Volume
1,831,028
0.61 Day's Range 0.8974
0.57 52 Week Range 4.44
Market Cap
Previous Close
0.582
Open
0.61
Last Trade Time
Financial Volume
US$ 1,253,225
VWAP
0.684438
Average Volume (3m)
68,462
Shares Outstanding
11,068,566
Dividend Yield
-
PE Ratio
-0.11
Earnings Per Share (EPS)
-5.99
Revenue
2.45M
Net Profit
-66.27M

About PAVmed Inc

PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others. PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others.

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
PAVmed Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker PAVM. The last closing price for PAVmed was US$0.58. Over the last year, PAVmed shares have traded in a share price range of US$ 0.57 to US$ 4.44.

PAVmed currently has 11,068,566 shares outstanding. The market capitalization of PAVmed is US$6.44 million. PAVmed has a price to earnings ratio (PE ratio) of -0.11.

PAVM Latest News

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule PR Newswire NEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024 /PRNewswire/ -- Lucid...

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters PR Newswire NEW YORK, Dec. 19, 2024 Partnership launched with fully-contracted...

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication PR Newswire NEW YORK, Dec. 11, 2024 Study demonstrates outstanding...

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones PR Newswire NEW YORK, Dec. 3, 2024 New convertible debt...

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test PR Newswire NEW YORK, Nov. 20, 2024 NEW YORK, Nov. 20, 2024 /PRNewswire/...

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK, Nov. 18, 2024 /PRNewswire/...

PAVmed Provides Business Update and Third Quarter 2024 Financial Results

PAVmed Provides Business Update and Third Quarter 2024 Financial Results PR Newswire NEW YORK, Nov. 14, 2024 Lucid reports record quarterly EsoGuard® revenue and completes clinical evidence...

Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication PR Newswire NEW YORK, Nov. 7...

Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers

Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers PR Newswire NEW YORK, Nov. 5, 2024 Industry veterans from leading cancer...

PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024

PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024 PR Newswire NEW YORK, Oct. 31, 2024 Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK, Oct. 31, 2024...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.191-24.80519480520.771.470.571215700.6362142CS
4-0.431-42.67326732671.011.470.571214030.85645015CS
12-0.581-50.08620689661.161.470.57684620.96292563CS
26-0.251-30.24096385540.831.90.57733341.03971637CS
52-3.311-85.11568123393.894.440.57701291.65729223CS
156-39.921-98.570370370440.543.80.5762345015.72067898CS
260-14.421-96.1415145.50.57115856247.646815CS

PAVM - Frequently Asked Questions (FAQ)

What is the current PAVmed share price?
The current share price of PAVmed is US$ 0.579
How many PAVmed shares are in issue?
PAVmed has 11,068,566 shares in issue
What is the market cap of PAVmed?
The market capitalisation of PAVmed is USD 6.44M
What is the 1 year trading range for PAVmed share price?
PAVmed has traded in the range of US$ 0.57 to US$ 4.44 during the past year
What is the PE ratio of PAVmed?
The price to earnings ratio of PAVmed is -0.11
What is the cash to sales ratio of PAVmed?
The cash to sales ratio of PAVmed is 2.84
What is the reporting currency for PAVmed?
PAVmed reports financial results in USD
What is the latest annual turnover for PAVmed?
The latest annual turnover of PAVmed is USD 2.45M
What is the latest annual profit for PAVmed?
The latest annual profit of PAVmed is USD -66.27M
What is the registered address of PAVmed?
The registered address for PAVmed is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the PAVmed website address?
The website address for PAVmed is www.pavmed.com
Which industry sector does PAVmed operate in?
PAVmed operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DRCTDirect Digital Holdings Inc
US$ 5.25
(854.55%)
68.54M
CHEKCheck Cap Ltd
US$ 2.24
(279.66%)
40.03M
SLGLSol Gel Technologies Ltd
US$ 1.57
(265.97%)
18.2M
RELIReliance Global Group Inc
US$ 3.08
(156.67%)
105.56M
TRAWTraws Pharma Inc
US$ 12.50
(149.00%)
28.23M
AILEiLearningEngines Inc
US$ 0.199
(-77.51%)
29.71M
MGOLMGO Global Inc
US$ 0.4765
(-49.84%)
14.17M
YHCLQR House Inc
US$ 1.11
(-36.57%)
1.28M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.4014
(-34.37%)
195.36M
ADGMAdagio Medical Holdings Inc
US$ 1.095
(-33.64%)
4.84M
EDBLEdible Garden AG Inc
US$ 0.3669
(54.35%)
408.02M
RGTIRigetti Computing Inc
US$ 10.945
(16.81%)
223.51M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.4014
(-34.37%)
192.3M
NVDANVIDIA Corporation
US$ 139.67
(3.69%)
174.65M
RIMEAlgorhythm Holdings Inc
US$ 0.0925
(21.07%)
155.8M

PAVM Discussion

View Posts
Monksdream Monksdream 6 months ago
PAVM under $2
👍️0
Monksdream Monksdream 11 months ago
PAVM new 52 week low
👍️0
Monksdream Monksdream 1 year ago
PAVM new 52 week low
👍️0
Mattrixinvest Mattrixinvest 1 year ago
Boom
👍️0
Monksdream Monksdream 1 year ago
PAVM new 52 week low
👍️0
Porterhouse10 Porterhouse10 3 years ago
Boom! Haaa
👍️0
Thunderstruck Thunderstruck 3 years ago
PAVM....Why the drop?? wasn't there just good news out in regards to this company and Lucid??
👍️0
Prfmf1 Prfmf1 3 years ago
Looks like they are trying to keep the stock around or under $7.50 to burn the August 20 options holders.
👍️0
TrendTrade2016 TrendTrade2016 3 years ago
not bullish...but bouncing. No microcaps are bullish right now...play with caution!!!
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 3 years ago
$PAVM Chart looking bullish here..
https://twitter.com/QuabbinR/status/1419357207557193733?s=20
👍️0
SurgeGuy2.0 SurgeGuy2.0 3 years ago
Was the CEO really arrested last week for fraud? Would it be the first time? Need to do a little more looking at it....right?
👍️0
SurgeGuy2.0 SurgeGuy2.0 3 years ago
Looking good like a stinky pile of crap. PAVM is going nowhere! lolzzzzzzzz
👍️0
bUrRpPPP! bUrRpPPP! 3 years ago
Looking good!
👍️0
Prfmf1 Prfmf1 3 years ago
What are your expectations going forward?
👍️0
TrendTrade2016 TrendTrade2016 4 years ago
PAVM there's a monster breaking out of its chains!!
👍️0
Prfmf1 Prfmf1 4 years ago
Short time PAVM holder and looking for big things to happen with this stock. My average buying price is in the low 4's.
👍️0
Flycanuck Flycanuck 4 years ago
Thanks for the tip. Will have a look .
👍️0
Flycanuck Flycanuck 4 years ago
Got Z warrants and shares too. Have not sold yet. Holding through this run up.
👍️0
rumrunner528 rumrunner528 4 years ago
Thank you, ConstitutionNow.

rum
👍️0
ConstitutionNow ConstitutionNow 4 years ago
Visit stocktwits.com at all? Lots of long term holders on there that have a good pulse on what's happening. I know Lucid spinoff is in the works, 3 clinics in phoenix about to open for eso testing. Eso 'in stock' at like 180 clinics around US. Do some quick numbers on a each test and you can see revs could scale quickly. Throw in nexflo, carpx etc and pavmed could be a great long term investment.
👍️0
rumrunner528 rumrunner528 4 years ago
Good for you, ConstitutionNow. I have z's and shares and have been lightening my position as it's run up. I wish I knew what's going on other than the recent PRs.

rum
👍️0
ConstitutionNow ConstitutionNow 4 years ago
Need a message at the top other than Clay...bad luck anytime he posts. Still sittin on a pile of z warrants...very bright future here! Eso, carpx etc...
👍️0
ClayTrader ClayTrader 4 years ago
* * $PAVM Video Chart 04-06-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Bertsllc Bertsllc 4 years ago
Cantor Fitzgerald analysis upgraded PAVM to overweight with the new target of $8.00.

https://www.benzinga.com/news/21/03/20397441/cantor-fitzgerald-initiates-coverage-on-pavmed-with-overweight-rating-announces-price-target-of-8

👍️0
ConstitutionNow ConstitutionNow 4 years ago
Little late in response here, but good analysis of the latest money raise. Solid move by management to get debt off books, lower dilution and cash leftover to fund commercialization. I think the market is starting to realize it now and we should move north on much more solid ground...where they can raise more cash at prices which don't hurt so much.
👍️0
Flycanuck Flycanuck 4 years ago
from the March 2020 S-3A (link below - page 5), I counted about 14 million shares could have been issued by the convertibles. So actually longer term they have about 4 million shares LESS outstanding plus all the cash you mentioned above. Win / Win.
https://www.sec.gov/Archives/edgar/data/1624326/000149315220005215/forms-3a.htm
👍️0
Flycanuck Flycanuck 4 years ago
"PAVmed intends to use the net proceeds from the offering to repay all of the company’s outstanding debt, including all outstanding convertible notes, with the balance to be used for working capital and general corporate purposes."

People don't realize, this doesn't increase dilution. It's a near wash in shares added, becasue the outstanding convertible shares are taken off the books by paying off the convertible holders. It increases float, but not outstanding.

Then the proceeds pay off all other debt, and the company still has around 30M from the offering to use for operations. It's a huge win for the company and shareholders.
👍️0
ClayTrader ClayTrader 4 years ago
* * $PAVM Video Chart 02-22-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
tone3 tone3 4 years ago
Must read article on Seeking Alpha. Target prices from a low of 5.50 up to 12 bucks
👍️0
ConstitutionNow ConstitutionNow 4 years ago
No odea what you are talking about...posted on twitter???????????
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
When will the new Offering/Dilution for 2021 be announced?

Saw it posted on twitter
👍️0
rumrunner528 rumrunner528 4 years ago
Thank you.
👍️0
ConstitutionNow ConstitutionNow 4 years ago
I've dug into those a bit, from what I can tell they are exercisable at a $1.60 a common share. Expire 2024. Slightly more risky than common but not much, if only one of their products take off, imo the warrants are much better investment dollar for dollar.
👍️0
rumrunner528 rumrunner528 4 years ago
👍️0
rumrunner528 rumrunner528 4 years ago
Does anyone know the terms of the PAVMZ warrants? The 10K is very confusing (or perhaps I'm just not that bright).
👍️0
jaj-dan jaj-dan 5 years ago
Gaining lots of credibility here.
👍️0
jaj-dan jaj-dan 5 years ago
PAVmed to join key indexes this month, shares +5% https://seekingalpha.com/news/3583795-pavmed-to-join-key-indexes-this-month-sharesplus-5
👍️0
jaj-dan jaj-dan 5 years ago
News from yesterday. Probably why the price is moving up.

Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor https://seekingalpha.com
👍️0
jaj-dan jaj-dan 5 years ago
I was just repeating the talking points from the conference call.
👍️0
Bickema Bickema 5 years ago
"PAVmed had cash and cash equivalents of $8.7 million as of March 31, 2020, compared with $6.2 million as of December 31, 2019. Subsequently, in late April 2020, the Company received approximately $3.6 million in proceeds from a private placement with an institutional investor for the sale of a Senior Secured Convertible Note."

Looks like they $12 million in cash no?
👍️0
Cubzgrl Cubzgrl 5 years ago
Moving north!!!! Lets get back to the $6.00s lol
👍️0
jaj-dan jaj-dan 5 years ago
https://ir.pavmed.com/news-events/press-releases/detail/121/pavmed-collaborates-with-canon-on-disappear-pediatric
👍️0
jaj-dan jaj-dan 5 years ago
PAVMed Is About To Enter The Commercialization Phase https://seekingalpha.com/article/4350867-pavmed-is-to-enter-commercialization-phase
👍️0
tjguy tjguy 5 years ago
Is the European approval of CarpX coming up soon?
👍️0
jaj-dan jaj-dan 5 years ago
I don’t really care if it dips here. There’s plenty of firms targeting this at $9-$10. It’s one of my best positions at the moment. I’m holding.
👍️0
jaj-dan jaj-dan 5 years ago
They didn’t really have much to say on the call. They were impacted by the virus with elective surgeries being postponed. They also commented that esoguard could be spun off into another company to raise money
👍️0
jaj-dan jaj-dan 5 years ago
There was only 1 analyst on the call. That’s not good. Management sounded very competent answering questions
👍️0
elcheepo elcheepo 5 years ago
thats a lot of cash they burned... they need to slow down
👍️0
jaj-dan jaj-dan 5 years ago
They said that their CarpX device will make 80-85% return
👍️0
jaj-dan jaj-dan 5 years ago
Re: PAVM
Some people may have bought hoping for a partnership deal announced. These things take time. You won't get a great deal if you are in a hurry.
👍️0

Your Recent History

Delayed Upgrade Clock